# Personalized Antiplatelet Secondary Stroke PRevenTion

> **NCT03979781** · PHASE2 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 90 (actual)

## Conditions studied

- Ischemic Stroke
- TIA

## Interventions

- **DRUG:** tailored antiplatelet selection
- **DRUG:** standard of care

## Key facts

- **NCT ID:** NCT03979781
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-11
- **Primary completion:** 2023-05-09
- **Final completion:** 2023-05-09
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03979781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03979781, "Personalized Antiplatelet Secondary Stroke PRevenTion". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03979781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*